Home / Indicators / Medicine spending vs Novel active substance launches Medicine spending vs Novel active substance launches Medicine spending and Novel active substance launches worldwide, compared over time.
Change the pair
Compare different indicators
The series
Over time Global, spaced by time
. Different units, drawn on separate scales and clipped to the years both
series publish — earlier history stays on each indicator's own page.
Read the values, not the heights.
Medicine spending
Unit: trillion USD · 2 observations
Line chart
Medicine spending Medicine spending. 2 observations from 2023 to 2030, ranging from 1.6 trillion USD to 2.6 trillion USD, of which 1 are forecasts. Latest value 2.6 trillion USD (2030).
trillion USD
0
0.5
1
1.5
2
2.5
3
2004
2008
2012
2016
2020
2024
2028
FORECAST
1.6
2.6
Medicine spending Medicine spending. 2 observations from 2023 to 2030, ranging from 1.6 trillion USD to 2.6 trillion USD, of which 1 are forecasts. Latest value 2.6 trillion USD (2030).
trillion USD
0
1
2
3
2004
2008
2012
2016
2020
2024
2028
FORECAST
1.6
2.6
Medicine spending Medicine spending. 2 observations from 2023 to 2030, ranging from 1.6 trillion USD to 2.6 trillion USD, of which 1 are forecasts. Latest value 2.6 trillion USD (2030).
trillion USD
0
1
2
3
2004
2008
2012
2016
2020
2024
2028
FORECAST
1.6
2.6
View the underlying data Novel active substance launches
Unit: count · 2 observations
Line chart Novel active substance launches Novel active substance launches. 2 observations from 2004–2023 to 2025, ranging from 79 to 942. Latest value 79 (2025).
0
200
400
600
800
1,000
2004
2008
2012
2016
2020
2024
2028
942
79
Novel active substance launches Novel active substance launches. 2 observations from 2004–2023 to 2025, ranging from 79 to 942. Latest value 79 (2025).
0
300
600
900
1,200
2004
2008
2012
2016
2020
2024
2028
942
79
Novel active substance launches Novel active substance launches. 2 observations from 2004–2023 to 2025, ranging from 79 to 942. Latest value 79 (2025).
0
300
600
900
1,200
2004
2008
2012
2016
2020
2024
2028
942
79
View the underlying data Provenance
Where these numbers come from Amount spent purchasing medicines from manufacturers before off-invoice discounts and rebates.
2 observations in Global · source
organisations: IQVIA
Total number of novel active substances launched.
2 observations in Global · source
organisations: IFPMA, IQVIA
Data published under CC BY 4.0 .
Series A as JSON · Series B as JSON